Parameter | Placebo, (n = 35) | Pemafibrate (K-877) mg/day | Fenofibrate mg/day 100 (n = 36) | |||
---|---|---|---|---|---|---|
0.05 (n = 34) | 0.1 (n = 37) | 0.2 (n = 36) | 0.4 (n = 36) | |||
Total C | 0.1 ± 9.8 | −2.7 ± 11.4 | −6.5 ± 11.9**†| −7.0 ± 11.3***†| −5.3 ± 12.9* | −6.0 ± 11.8**†|
Non-HDL-C | 0.7 ± 12.8 | −5.8 ± 12.4* | −11.8 ± 14.0***†††| −12.2 ± 13.8***†††| −10.5 ± 14.2***†††| −10.1 ± 14.2***††|
VLDL-Ca | 13.3 ± 38.9 | −24.3 ± 24.0***†††| −37.3 ± 26.7***†††| −43.8 ± 24.0***†††| −48.4 ± 27.5***†††| −25.8 ± 29.7***†††|
LDL-Ca | −6.3 ± 16.2* | 8.9 ± 21.3*†| 8.3 ± 29.4†| 5.0 ± 28.0 | 7.4 ± 26.5†| 5.3 ± 23.4†|
Remnant C | 38.7 ± 75.7** | −32.3 ± 33.8***†††| −42.8 ± 29.4***†††| −48.3 ± 28.1***†††| −50.1 ± 31.8***†††| −31.8 ± 35.0***†††|
ApoB | −2.0 ± 9.9 | −1.4 ± 13.6 | −8.9 ± 13.6***†| −7.8 ± 15.0** | −8.1 ± 11.6*** | −5.7 ± 14.4* |
ApoB48 | 54.6 ± 171.1 | −28.4 ± 43.1***†††| −43.1 ± 47.1***†††| −55.9 ± 25.6***†††| −51.2 ± 29.3***†††| −37.9 ± 42.9***†††|
ApoCIII | 7.9 ± 27.4 | −22.2 ± 14.4***†††| −29.0 ± 18.9***†††| −34.6 ± 17.7***†††| −33.4 ± 19.2***†††| −27.2 ± 18.9***†††|